Accelerate Pheno System
Overview
The Accelerate Pheno System is a fully automated in vitro diagnostic platform designed for rapid identification (ID) and antimicrobial susceptibility testing (AST) directly from positive blood cultures. It is NOT an AI tool for a physician directory. This system significantly reduces the time required to identify pathogens and determine their susceptibility to various antibiotics, often providing results in hours compared to the days required by conventional methods. Utilizing technologies like fluorescence in situ hybridization (FISH) for identification and morphokinetic cellular analysis (MCA) for susceptibility testing, the Accelerate Pheno System helps clinicians make targeted, life-saving therapy decisions earlier for patients with bacteremia and sepsis. This leads to improved patient outcomes, reduced length of hospital stay, and supports antimicrobial stewardship efforts by enabling optimal antibiotic selection and de-escalation.
Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Key Features
- Rapid Pathogen Identification (ID) in ~90 minutes to 2 hours
- Rapid Antimicrobial Susceptibility Testing (AST) in ~5 to 7 hours
- Directly from positive blood cultures
- Fully automated workflow with minimal hands-on time
- Utilizes Fluorescence In Situ Hybridization (FISH) for ID
- Employs Morphokinetic Cellular Analysis (MCA) for AST
- Provides Minimum Inhibitory Concentration (MIC) results
- Supports targeted antibiotic therapy and de-escalation
- Reduces time to optimal therapy by up to 26.4 hours and length of stay by up to 2.2 days
- Expert rule system for susceptibility interpretation based on FDA/CLSI/EUCAST breakpoints
Use Cases
- Rapid diagnosis of bloodstream infections
- Guiding antibiotic therapy for sepsis patients
- Enhancing antimicrobial stewardship programs
- Reducing hospital length of stay for patients with infections
- Optimizing antibiotic selection and dosage
- Detecting antibiotic resistance faster
What Physicians Need to Know
The Accelerate Pheno System provides rapid identification and antimicrobial susceptibility testing directly from positive blood cultures, significantly reducing the time to results compared to traditional methods. This allows for earlier optimization of antibiotic therapy, which is crucial for patients with serious infections like sepsis. The system delivers MIC values and categorical interpretations based on established guidelines (CLSI/EUCAST), enabling informed decisions on antibiotic selection, dosage, and de-escalation. While highly accurate for on-panel organisms, be aware that polymicrobial infections or pathogens not included in the panel may require complementary testing. The integration with LIS and automated alerts can further streamline communication and facilitate timely clinical interventions.
The Accelerate Pheno System offers LIS/LIMS integration for automated reporting and alerts, enhancing workflow efficiency and communication within the laboratory and with clinical teams. It is designed to be a fully automated platform, working in conjunction with its proprietary Accelerate PhenoTest BC kit.
Details
| Category | Lab & Diagnostics, Triage & ER/ICU AI |
| Pricing | Variable |
| Deployment | On-premise (hospital microbiology laboratories) |
| Compliance | |
| BAA Available | Unknown |
| HIPAA Compliant | Unknown |
| FDA Status | Yes AI-estimated |
| Integrations | |
| EHR | Not specified |
| Specialties | Critical Care, Infectious Disease, Laboratory Medicine |
FDA clearance history
This product’s FDA authorization. From FDA’s list of AI-enabled medical devices; each number links to FDA’s record.
| Decision date | Number | Name as listed by FDA |
| 2020-09-15 | K192665 510(k) | Accelerate Pheno System |
Ratings & Reviews
No reviews yet. Be the first to review this tool!
Rate Accelerate Pheno System
Videos
Product demos, reviews, and walkthroughs for Accelerate Pheno System.
What the Accelerate Pheno System Means To Us
Accelerate Diagnostics





